|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
01.06.2022
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
In accordance with the Corporate Governance Communiqué, Capital Markets Board (CMB) has resolved that, in relation to Mrs. Dr. Katja Windt, who is nominated as Independent Board Member pursuant to the Communiqué on Corporate Governance, any negative opinion need not be expressed.
Although Mrs. Katja Dr. Windt does not meet the criteria "To be located in Turkey per Income Tax Legislation" defined in paragraph (d) of Article 4.3.6 of the Communique due to living abroad, this condition is being evaluated within the provision "fulfilment of independence criteria stated in paragraph (d) of Article 4.3.6 by minimum half of the independent members is sufficient" specified in clause 6 of Article 5 in the Communique.
Moreover, for our Company with singnificiant foreign investor ratio level in the shares traded in Stock Exchange and one of two strategic major shareholders is foreign, having a foreign independent member in the Board of Directors is a significant contribution for the investors.
Therefore, in accordance with the resolution of Board of Directors dated 1.06.2022, Mrs. Dr. Katja Windt has been appointed as Independent Board Member to complete the remaining term of office of his predecessor subject to the approval of shareholders at the earliest general assembly meeting.
This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||